LONDON – 06 July, 2016 – COS 2016, the 4th annual Clinical Outsourcing Strategies Symposium will be held in Brussels, Belgium on the 20th & 21st of October 2016. Sixteen prestigious professionals within the pharmaceutical industry have confirmed their speaking positions. The speaking panel includes professionals such as Mr Mitchell Silva, CEO, Esperity, Mrs Lidia Cappellina, Head of Outsourcing, Chiesi Farmaceutici, Mrs Neta Gershon, Business Infrastructures, Teva and Mr Pasi Piitulainen, Head of Global Procurement, Actelion. With a capacity of 150 participants, COS will be held along with the Clinical Trial Supplies Network (CTS) – 2nd Annual Symposium on the same dates and venue.
The Clinical Outsourcing Strategies conference is an annual event and a dedicated platform for Clinical Outsourcing and Clinical Operational departments from Bio/Pharma-Biotech companies; Sales, Business Development and Marketing colleagues from Clinical Research Organizations (CRO), Clinical Research Service and Solution providers. Over the past four years, the meeting has gained a reputation for engaging and tackling the least discussed topics. It is a platform of exceptional intimacy in exchanging information among stakeholders concerned with the entire clinical trial outsourcing cycle.
The 4th annual COS symposium has been designed to engage a more ‘bow tie’ communication approach so to create an agreeable environment for Sponsors-&-CROs/Vendors. The process is Omni-encompassing of all processes and stakeholders from CRO selection to after-contract obligations. While the Clinical Outsourcing Strategies conference is highly focused on creating an atmosphere of optimisation based on Transparency and Accountability when engaging the Clinical Trial Outsourcing Journey.
Business Dialogue Worldwide Limited
+44 (0) 207 096 1152
Distributed by Press Release Jet
Company Name: Business Dialogue
Contact Person: Evdokia Gerasimou
Country: United States